Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2015

01-09-2015 | Original Article

mTOR-Dependent Suppression of Remnant Liver Regeneration in Liver Failure After Massive Liver Resection in Rats

Authors: Dong Xin Zhang, Chong Hui Li, Ai Qun Zhang, Shan Jiang, Yan Hua Lai, Xin Lan Ge, Ke Pan, Jia Hong Dong

Published in: Digestive Diseases and Sciences | Issue 9/2015

Login to get access

Abstract

Background and Aims

Massive hepatectomy often leads to fatal liver failure because of a small remnant liver volume. The aim of this study was to investigate the potential mechanisms leading to liver failure.

Methods

Sprague–Dawley rats had performed a sham operation, 85 % partial hepatectomy (PH) or 90 % PH, and all had free access to water with or without supplemented glucose. Liver function and survival were evaluated. Liver parenchymal injury was assessed by evaluating hepatic pathology, blood biochemistry, and apoptotic and necrotic alterations. The regeneration response was assessed by the weight gain of the remnant liver, hepatocyte proliferation markers, and regeneration-related molecules.

Results

The 90 % hepatectomy resulted in a significantly lower survival rate and impaired liver function; however, no significant more serious liver parenchymal injuries were detected. TNF-α, HGF, myc and IL-6 were either similarly expressed or overexpressed; however, the increase in remnant liver weight, mitotic index, and the presence of Ki-67 and PCNA were significantly lower in the 90 %-hepatectomized rats. mTOR, p70S6K and 4EBP1 were not activated in the remnant liver after a 90 % hepatectomy as obviously as those after an 85 % hepatectomy, which was concomitant with the higher expression of phospho-AMPK and a lower intrahepatic ATP level. Glucose treatment significantly improved the survival rate of 90 %-hepatectomized rats.

Conclusions

Suppression of remnant liver regeneration was observed in the 90 % PH and contributed to fatal liver failure. This suppressed liver regenerative capacity was related to the inhibited activation of mTOR signaling.
Literature
1.
go back to reference Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011;253:656–665.CrossRefPubMed Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011;253:656–665.CrossRefPubMed
2.
go back to reference de Santibanes E, Alvarez FA, Ardiles V. How to avoid postoperative liver failure: a novel method. World J Surg. 2012;36:125–128.CrossRefPubMed de Santibanes E, Alvarez FA, Ardiles V. How to avoid postoperative liver failure: a novel method. World J Surg. 2012;36:125–128.CrossRefPubMed
3.
go back to reference Squires MH, Lad NL, Fisher SB, et al. The effect of preoperative renal insufficiency on postoperative outcomes after major hepatectomy: a multi-institutional analysis of 1,170 patients. J Am Coll Surg. 2014;219:914–922.CrossRefPubMed Squires MH, Lad NL, Fisher SB, et al. The effect of preoperative renal insufficiency on postoperative outcomes after major hepatectomy: a multi-institutional analysis of 1,170 patients. J Am Coll Surg. 2014;219:914–922.CrossRefPubMed
4.
go back to reference Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am J Surg. 2009;197:686–690.CrossRefPubMed Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am J Surg. 2009;197:686–690.CrossRefPubMed
5.
go back to reference Garcea G, Maddern GJ. Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg. 2009;16:145–155.CrossRefPubMed Garcea G, Maddern GJ. Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg. 2009;16:145–155.CrossRefPubMed
6.
go back to reference Jin X, Zhang Z, Beer-Stolz D, et al. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology. 2007;46:802–812.CrossRefPubMed Jin X, Zhang Z, Beer-Stolz D, et al. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology. 2007;46:802–812.CrossRefPubMed
7.
go back to reference Hammond JS, Guha IN, Beckingham IJ, et al. Prediction, prevention and management of postresection liver failure. Br J Surg. 2011;98:1188–1200.CrossRefPubMed Hammond JS, Guha IN, Beckingham IJ, et al. Prediction, prevention and management of postresection liver failure. Br J Surg. 2011;98:1188–1200.CrossRefPubMed
8.
go back to reference Hasegawa S, Kubota T, Fukuyama N, et al. Apoptosis of hepatocytes is a main cause of inducing lethal hepatic failure after excessive hepatectomy in rats. Transplant Proc. 1999;31:558–559.CrossRefPubMed Hasegawa S, Kubota T, Fukuyama N, et al. Apoptosis of hepatocytes is a main cause of inducing lethal hepatic failure after excessive hepatectomy in rats. Transplant Proc. 1999;31:558–559.CrossRefPubMed
9.
go back to reference Boermeester MA, Straatsburg IH, Houdijk AP, et al. Endotoxin and interleukin-1 related hepatic inflammatory response promotes liver failure after partial hepatectomy. Hepatology. 1995;22:1499–1506.PubMed Boermeester MA, Straatsburg IH, Houdijk AP, et al. Endotoxin and interleukin-1 related hepatic inflammatory response promotes liver failure after partial hepatectomy. Hepatology. 1995;22:1499–1506.PubMed
10.
go back to reference Lehmann K, Tschuor C, Rickenbacher A, et al. Liver failure after extended hepatectomy in mice is mediated by a p21-dependent barrier to liver regeneration. Gastroenterology. 2012;143:1609–1619.CrossRefPubMed Lehmann K, Tschuor C, Rickenbacher A, et al. Liver failure after extended hepatectomy in mice is mediated by a p21-dependent barrier to liver regeneration. Gastroenterology. 2012;143:1609–1619.CrossRefPubMed
11.
go back to reference Pan N, Lv X, Liang R, et al. Suppression of graft regeneration, not ischemia/reperfusion injury, is the primary cause of small-for-size syndrome after partial liver transplantation in mice. PLoS ONE. 2014;9:e93636.PubMedCentralCrossRefPubMed Pan N, Lv X, Liang R, et al. Suppression of graft regeneration, not ischemia/reperfusion injury, is the primary cause of small-for-size syndrome after partial liver transplantation in mice. PLoS ONE. 2014;9:e93636.PubMedCentralCrossRefPubMed
13.
go back to reference Kooby DA, Zakian KL, Challa SN, et al. Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determine safe timing of chemotherapy after hepatic resection. Cancer Res. 2000;60:3800–3806.PubMed Kooby DA, Zakian KL, Challa SN, et al. Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determine safe timing of chemotherapy after hepatic resection. Cancer Res. 2000;60:3800–3806.PubMed
14.
go back to reference Ozawa K, Yamada T, Ukikusa M, et al. Mitochondrial phosphorylative activity and DNA synthesis in regenerating liver of diabetic rats. J Surg Res. 1981;31:38–45.CrossRefPubMed Ozawa K, Yamada T, Ukikusa M, et al. Mitochondrial phosphorylative activity and DNA synthesis in regenerating liver of diabetic rats. J Surg Res. 1981;31:38–45.CrossRefPubMed
15.
go back to reference Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471–484.CrossRefPubMed Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471–484.CrossRefPubMed
16.
go back to reference Morita T, Togo S, Kubota T, et al. Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg. 2002;9:352–359.CrossRefPubMed Morita T, Togo S, Kubota T, et al. Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg. 2002;9:352–359.CrossRefPubMed
17.
go back to reference Kumar S, Zou Y, Bao Q, et al. Proteomic analysis of immediate-early response plasma proteins after 70% and 90% partial hepatectomy. Hepatol Res. 2013;43:876–889.PubMedCentralCrossRefPubMed Kumar S, Zou Y, Bao Q, et al. Proteomic analysis of immediate-early response plasma proteins after 70% and 90% partial hepatectomy. Hepatol Res. 2013;43:876–889.PubMedCentralCrossRefPubMed
19.
go back to reference Mendes-Braz M, Elias-Miro M, Kleuser B, et al. The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. Liver Int. 2014;34:e271–e289.CrossRefPubMed Mendes-Braz M, Elias-Miro M, Kleuser B, et al. The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. Liver Int. 2014;34:e271–e289.CrossRefPubMed
20.
go back to reference Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.CrossRefPubMed Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.CrossRefPubMed
21.
go back to reference de Graaf W, Bennink RJ, Heger M, et al. Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med. 2011;52:294–302.CrossRefPubMed de Graaf W, Bennink RJ, Heger M, et al. Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med. 2011;52:294–302.CrossRefPubMed
22.
go back to reference Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251–262.CrossRefPubMed Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251–262.CrossRefPubMed
23.
go back to reference Hardie DG. AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol. 2015;33:1–7.CrossRefPubMed Hardie DG. AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol. 2015;33:1–7.CrossRefPubMed
24.
go back to reference Gaub J, Iversen J. Rat liver regeneration after 90% partial hepatectomy. Hepatology. 1984;4:902–904.CrossRefPubMed Gaub J, Iversen J. Rat liver regeneration after 90% partial hepatectomy. Hepatology. 1984;4:902–904.CrossRefPubMed
25.
go back to reference Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–724.CrossRefPubMed Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–724.CrossRefPubMed
26.
go back to reference Makino H, Togo S, Kubota T, et al. A good model of hepatic failure after excessive hepatectomy in mice. J Surg Res. 2005;127:171–176.CrossRefPubMed Makino H, Togo S, Kubota T, et al. A good model of hepatic failure after excessive hepatectomy in mice. J Surg Res. 2005;127:171–176.CrossRefPubMed
27.
go back to reference Panis Y, McMullan DM, Emond JC. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery. 1997;121:142–149.CrossRefPubMed Panis Y, McMullan DM, Emond JC. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery. 1997;121:142–149.CrossRefPubMed
28.
go back to reference Ohashi N, Hori T, Chen F, et al. Matrix metalloproteinase-9 contributes to parenchymal hemorrhage and necrosis in the remnant liver after extended hepatectomy in mice. World J Gastroenterol. 2012;18:2320–2333.PubMedCentralCrossRefPubMed Ohashi N, Hori T, Chen F, et al. Matrix metalloproteinase-9 contributes to parenchymal hemorrhage and necrosis in the remnant liver after extended hepatectomy in mice. World J Gastroenterol. 2012;18:2320–2333.PubMedCentralCrossRefPubMed
29.
30.
go back to reference Volarevic S, Stewart MJ, Ledermann B, et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science. 2000;288:2045–2047.CrossRefPubMed Volarevic S, Stewart MJ, Ledermann B, et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science. 2000;288:2045–2047.CrossRefPubMed
31.
go back to reference Hara K, Maruki Y, Long X, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 2002;110:177–189.CrossRefPubMed Hara K, Maruki Y, Long X, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 2002;110:177–189.CrossRefPubMed
32.
go back to reference Kantidakis T, Ramsbottom BA, Birch JL, et al. mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci USA. 2010;107:11823–11828.PubMedCentralCrossRefPubMed Kantidakis T, Ramsbottom BA, Birch JL, et al. mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci USA. 2010;107:11823–11828.PubMedCentralCrossRefPubMed
33.
go back to reference Panasyuk G, Patitucci C, Espeillac C, et al. The role of the mTOR pathway during liver regeneration and tumorigenesis. Ann Endocrinol (Paris). 2013;74:121–122.CrossRef Panasyuk G, Patitucci C, Espeillac C, et al. The role of the mTOR pathway during liver regeneration and tumorigenesis. Ann Endocrinol (Paris). 2013;74:121–122.CrossRef
34.
go back to reference Fouraschen SM, de Ruiter PE, Kwekkeboom J, et al. mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment. World J Transplant. 2013;3:36–47.PubMedCentralCrossRefPubMed Fouraschen SM, de Ruiter PE, Kwekkeboom J, et al. mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment. World J Transplant. 2013;3:36–47.PubMedCentralCrossRefPubMed
35.
go back to reference Kawaguchi T, Kodama T, Hikita H, et al. Carbamazepine promotes liver regeneration and survival in mice. J Hepatol. 2013;59:1239–1245.CrossRefPubMed Kawaguchi T, Kodama T, Hikita H, et al. Carbamazepine promotes liver regeneration and survival in mice. J Hepatol. 2013;59:1239–1245.CrossRefPubMed
36.
go back to reference Buitrago-Molina LE, Pothiraju D, Lamle J, et al. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage. Hepatology. 2009;50:500–509.CrossRefPubMed Buitrago-Molina LE, Pothiraju D, Lamle J, et al. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage. Hepatology. 2009;50:500–509.CrossRefPubMed
37.
go back to reference Sanli T, Steinberg GR, Singh G, et al. AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther. 2014;15:156–169.PubMedCentralCrossRefPubMed Sanli T, Steinberg GR, Singh G, et al. AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther. 2014;15:156–169.PubMedCentralCrossRefPubMed
39.
go back to reference Rehman H, Sun J, Shi Y, et al. NIM811 prevents mitochondrial dysfunction, attenuates liver injury, and stimulates liver regeneration after massive hepatectomy. Transplantation. 2011;91:406–412.PubMedCentralPubMed Rehman H, Sun J, Shi Y, et al. NIM811 prevents mitochondrial dysfunction, attenuates liver injury, and stimulates liver regeneration after massive hepatectomy. Transplantation. 2011;91:406–412.PubMedCentralPubMed
40.
go back to reference Nakatani T, Ozawa K, Asano M, et al. Differences in predominant energy substrate in relation to the resected hepatic mass in the phase immediately after hepatectomy. J Lab Clin Med. 1981;97:887–898.PubMed Nakatani T, Ozawa K, Asano M, et al. Differences in predominant energy substrate in relation to the resected hepatic mass in the phase immediately after hepatectomy. J Lab Clin Med. 1981;97:887–898.PubMed
Metadata
Title
mTOR-Dependent Suppression of Remnant Liver Regeneration in Liver Failure After Massive Liver Resection in Rats
Authors
Dong Xin Zhang
Chong Hui Li
Ai Qun Zhang
Shan Jiang
Yan Hua Lai
Xin Lan Ge
Ke Pan
Jia Hong Dong
Publication date
01-09-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3676-y

Other articles of this Issue 9/2015

Digestive Diseases and Sciences 9/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.